Vistagen Therapeutics, Inc.
US ˙ NasdaqCM ˙ US92840H4002

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jon S Saxe. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jon S Saxe har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VTGN / Vistagen Therapeutics, Inc. Director 100.000
US:DRRX / DURECT Corporation Director 55.000
US:SCLN / SciClone Pharmaceuticals, Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jon S Saxe. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb VTGN / Vistagen Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VTGN / Vistagen Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-08-21 VTGN SAXE JON S 30.000 0,6900 1.000 20,7000 20.700 314 3105 3.084.300 14.900,00
2019-03-14 VTGN SAXE JON S 7.920 1,2735 264 38,2050 10.086
2019-03-13 VTGN SAXE JON S 12.080 1,2584 403 37,7520 15.201

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VTGN / Vistagen Therapeutics, Inc. Insider Trades
Insidersalg VTGN / Vistagen Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VTGN / Vistagen Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VTGN / Vistagen Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jon S Saxe som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-03-03 2022-03-01 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 100.000 100.000
2021-03-22 2021-03-19 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -2.500 0 -100,00
2021-03-22 2021-03-19 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
M - Exercise 2.500 5.751 76,90 1,50 3.750 8.626
2021-01-04 2020-12-30 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2020-08-24 2020-08-21 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
P - Purchase 30.000 50.000 150,00 0,69 20.700 34.500
2020-06-18 2020-06-17 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55.000 55.000
2020-04-27 2020-04-23 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-10-22 2019-10-21 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-06-20 2019-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55.000 55.000
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.900 150.000 1,97 0,56 1.623 83.940
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 74 147.100 0,05 0,56 41 82.229
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 626 147.026 0,43 0,56 350 82.158
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 3.449 146.400 2,41 0,56 1.922 81.589
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.400 142.951 0,99 0,55 775 79.152
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 141.551 0,28 0,55 221 78.249
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.800 141.151 1,29 0,55 993 77.901
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 139.351 0,22 0,55 165 76.643
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 500 139.051 0,36 0,55 275 76.464
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.400 138.551 1,02 0,55 764 75.635
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 137.151 0,22 0,55 164 74.816
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.751 136.851 1,30 0,55 955 74.639
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 135.100 0,07 0,55 55 73.643
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 7.898 135.000 6,21 0,54 4.304 73.562
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 127.102 0,08 0,54 54 69.194
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 127.002 0,24 0,54 163 69.127
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 15 126.702 0,01 0,54 8 68.926
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 126.687 0,16 0,54 109 68.905
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.200 126.487 0,96 0,54 653 68.784
2019-06-11 2019-06-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 287 125.287 0,23 0,54 156 68.006
2019-05-28 2019-05-23 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2019-05-28 2019-05-24 4 DRRX DURECT CORP
Common Stock
P - Purchase 4.600 125.000 3,82 0,63 2.899 78.775
2019-05-28 2019-05-24 4 DRRX DURECT CORP
Common Stock
P - Purchase 21.335 120.400 21,54 0,63 13.443 75.864
2019-05-28 2019-05-24 4 DRRX DURECT CORP
Common Stock
P - Purchase 4.065 99.065 4,28 0,63 2.561 62.411
2019-05-15 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.200 95.000 2,37 0,71 1.558 67.260
2019-05-15 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 6.500 92.800 7,53 0,70 4.581 65.405
2019-05-15 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 900 86.300 1,05 0,70 634 60.781
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 800 85.400 0,95 0,70 563 60.079
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.085 84.600 2,53 0,70 1.465 59.448
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 37 82.515 0,04 0,70 26 57.926
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 3.900 82.478 4,96 0,70 2.737 57.891
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.798 78.578 2,34 0,70 1.260 55.083
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.600 76.780 2,13 0,70 1.121 53.815
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 4.826 75.180 6,86 0,70 3.382 52.686
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 70.354 0,57 0,70 280 49.297
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 864 69.954 1,25 0,70 605 49.003
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.584 69.090 2,35 0,70 1.109 48.391
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.391 67.506 2,10 0,70 974 47.274
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 595 66.115 0,91 0,70 416 46.175
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 65.520 0,46 0,70 209 45.681
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 4.900 65.220 8,12 0,70 3.407 45.347
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.232 60.320 2,09 0,70 856 41.934
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.000 59.088 1,72 0,69 694 41.031
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 58.088 0,69 0,69 278 40.319
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 895 57.688 1,58 0,69 621 40.035
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 779 56.793 1,39 0,69 538 39.250
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 569 56.014 1,03 0,69 393 38.683
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 489 55.445 0,89 0,69 338 38.268
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.195 54.956 2,22 0,69 825 37.920
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 3.100 53.761 6,12 0,69 2.138 37.084
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 50.661 0,40 0,69 138 34.860
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 699 50.461 1,40 0,68 479 34.566
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 900 49.762 1,84 0,68 613 33.913
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 287 48.862 0,59 0,68 196 33.295
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.995 48.575 6,57 0,68 2.037 33.046
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 380 45.580 0,84 0,68 258 31.004
2019-05-14 2019-05-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 45.200 0,44 0,68 136 30.754
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 45.000 0,22 0,82 82 36.680
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 44.900 0,67 0,82 245 36.607
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 44.600 0,45 0,82 163 36.385
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 44.400 0,45 0,82 163 36.226
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 600 44.200 1,38 0,82 490 36.067
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 43.600 0,23 0,82 82 35.582
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 43.500 0,23 0,82 82 35.509
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 43.400 0,46 0,82 163 35.436
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 800 43.200 1,89 0,82 653 35.281
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 42.400 0,24 0,82 82 34.632
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 42.300 0,24 0,82 82 34.555
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 900 42.200 2,18 0,82 735 34.486
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 600 41.300 1,47 0,82 490 33.754
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 40.700 0,74 0,82 245 33.293
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 600 40.400 1,51 0,82 491 33.063
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 39.800 0,51 0,82 164 32.580
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 625 39.600 1,60 0,82 512 32.436
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 600 38.975 1,56 0,82 492 31.928
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 38.375 0,52 0,82 164 31.441
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 38.175 0,26 0,82 82 31.281
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 38.075 1,06 0,82 328 31.202
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 37.675 0,80 0,82 246 30.878
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 3.441 37.375 10,14 0,82 2.821 30.644
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 4.600 33.934 15,68 0,82 3.772 27.826
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 748 29.334 2,62 0,82 614 24.060
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 28.586 0,70 0,82 164 23.449
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 28.386 0,35 0,82 82 23.288
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.800 28.286 6,80 0,82 1.478 23.223
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 26.486 0,76 0,82 164 21.750
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 26.286 1,15 0,82 246 21.591
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 1.200 25.986 4,84 0,82 986 21.347
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 24.786 1,64 0,82 329 20.369
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 24.386 0,41 0,82 82 20.050
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 24.286 0,41 0,82 82 19.970
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 24.186 0,42 0,82 82 19.893
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 386 24.086 1,63 0,82 318 19.813
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.400 23.700 11,27 0,82 1.975 19.505
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 21.300 0,47 0,82 82 17.536
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 100 21.200 0,47 0,82 82 17.456
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 500 21.100 2,43 0,82 412 17.376
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 20.600 0,98 0,82 165 16.966
2019-03-15 2019-03-13 4 DRRX DURECT CORP
Common Stock
P - Purchase 400 20.400 2,00 0,82 330 16.830
2019-03-14 2019-03-14 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
P - Purchase 7.920 20.000 65,56 1,27 10.086 25.470
2019-03-14 2019-03-13 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
P - Purchase 12.080 12.080 1,26 15.201 15.201
2019-01-30 2019-01-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -1.000 0 -100,00
2019-01-30 2019-01-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -375 0 -100,00
2019-01-30 2019-01-29 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
M - Exercise 1.000 3.251 44,42 1,50 1.500 4.876
2019-01-30 2019-01-29 4 VTGN VistaGen Therapeutics, Inc.
Common Stock
M - Exercise 375 2.251 19,99 1,50 562 3.376
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -35.000 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -25.000 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -25.000 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 2.500 2.500
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -2.500 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7.500 7.500
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -7.500 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 1.000 1.000
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -1.000 0 -100,00
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 375 375
2018-08-31 2018-08-29 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -375 0 -100,00
2018-08-06 2018-08-05 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2018-06-20 2018-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55.000 55.000
2018-02-05 2018-02-02 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 100.000 100.000
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 0,28 -8.400
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 2,03 -60.900
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 6,08 -182.400
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 6,05 -181.500
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 4,40 -132.000
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 5,14 -154.200
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 8,17 -245.100
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 8,95 -268.500
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -30.000 0 -100,00 9,43 -282.900
2017-10-16 2017-10-13 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -135.000 0 -100,00 11,18 -1.509.300
2017-09-20 2017-09-19 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 16.038 71.038 29,16 1,06 17.000 75.300
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55.000 55.000
2017-06-09 2017-06-08 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2017-04-28 2017-04-26 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2017-02-23 2017-02-22 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -12.700 0 -100,00
2017-02-23 2017-02-22 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
M - Exercise 12.700 135.000 10,38 2,61 33.147 352.350
2017-02-17 2017-02-16 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -17.300 12.700 -57,67
2017-02-17 2017-02-16 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
M - Exercise 17.300 122.300 16,48 2,61 45.153 319.203
2016-11-10 2016-11-09 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-06-23 2016-06-22 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35.000 35.000
2016-06-21 2016-06-19 4 VTGN VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-06-13 2016-06-09 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2016-04-04 2016-03-31 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14.423 14.423 1,04 15.000 15.000
2016-01-06 2016-01-04 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30.000 0 -100,00
2016-01-06 2016-01-04 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 105.000 40,00 2,46 73.800 258.300
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 50.000 50.000
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -50.000 0 -100,00
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 20.000 20.000
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -20.000 0 -100,00
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 3.250 3.250
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -3.250 0 -100,00
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 7.500 7.500
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -7.500 0 -100,00
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 2.500 2.500
2015-11-13 2015-11-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -2.500 0 -100,00
2015-09-03 2015-09-02 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 50.000 50.000
2015-06-16 2015-06-15 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35.000 35.000
2015-06-12 2015-06-11 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2015-03-30 2015-03-26 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 11.111 11.111
2015-03-05 2015-03-04 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30.000 0 -100,00
2015-03-05 2015-03-04 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 75.000 66,67 3,27 98.100 245.250
2015-01-13 2015-01-11 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 20.000 20.000
2014-06-17 2014-06-16 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35.000 35.000
2014-06-16 2014-06-12 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2014-04-01 2014-03-28 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14.423 14.423
2014-03-21 2014-03-19 4 VSTA VistaGen Therapeutics, Inc.
Warrant
J - Other 65.000 65.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 50.000 50.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -50.000 0 -100,00
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
D - Sale to Issuer -50.000 0 -100,00
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 150.000 150.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -150.000 0 -100,00
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7.500 7.500
2013-12-26 2013-12-20 4 VSTA VistaGen Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -7.500 0 -100,00
2013-06-28 2013-06-27 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2013-06-26 2013-06-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35.000 35.000
2013-03-06 2013-03-03 4 VSTA VistaGen Therapeutics, Inc.
Warrant
J - Other 150.000 150.000
2013-02-07 2013-02-05 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 18.987 18.987
2012-12-14 2012-12-12 4 DRRX DURECT CORP
Common Stock
P - Purchase 5.300 27.810 23,55 0,91 4.812 25.249
2012-12-14 2012-12-12 4 DRRX DURECT CORP
Common Stock
P - Purchase 9.700 22.510 75,72 0,91 8.808 20.439
2012-08-29 2012-08-28 4 DRRX DURECT CORP
Common Stock
P - Purchase 5.000 12.810 64,02 0,98 4.900 12.554
2012-08-29 2012-08-27 4 DRRX DURECT CORP
Common Stock
P - Purchase 2.810 7.810 56,20 0,96 2.698 7.498
2012-08-27 2012-08-23 4 DRRX DURECT CORP
Common Stock
P - Purchase 5.000 5.000 1,00 5.000 5.000
2012-06-21 2012-06-20 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 25.000 25.000
2012-06-08 2012-06-07 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2012-05-03 2012-05-02 4 SCLN SCICLONE PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2012-05-03 2012-05-02 4 SCLN SCICLONE PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 45.000 80,00 3,84 76.800 172.800
2012-02-15 2012-02-13 4 VSTA VistaGen Therapeutics, Inc.
Warrant for Common Stock
A - Award 50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)